ArticleJournal of cancer research and clinical oncology2024

CRISPR/Cas9-based genome-wide screening for metastasis ability identifies FCGR1A regulating the metastatic process of ovarian cancer by targeting LSP1.

Yingying Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.